RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-8.53%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$3.75B
AUM Growth
+$3.75B
Cap. Flow
-$57.3M
Cap. Flow %
-1.53%
Top 10 Hldgs %
47.18%
Holding
110
New
14
Increased
9
Reduced
11
Closed
22

Top Buys

1
VERU icon
Veru
VERU
$89.3M
2
PEPG icon
PepGen
PEPG
$80.7M
3
NSTG
NanoString Technologies, Inc.
NSTG
$45.5M
4
ACRS icon
Aclaris Therapeutics
ACRS
$36M
5
WVE icon
Wave Life Sciences
WVE
$30.6M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$60.4M
2
MGNX icon
MacroGenics
MGNX
$53.8M
3
NVAX icon
Novavax
NVAX
$51M
4
CNTA
Centessa Pharmaceuticals
CNTA
$32.1M
5
CCXI
ChemoCentryx, Inc.
CCXI
$29M

Sector Composition

1 Healthcare 98.19%
2 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NTRA icon
26
Natera
NTRA
$23B
$46.4M 1.24%
1,310,289
– –
ABOS icon
27
Acumen Pharmaceuticals
ABOS
$84.2M
$45.9M 1.22%
9,770,773
– –
NSTG
28
DELISTED
NanoString Technologies, Inc.
NSTG
$45.5M 1.21%
+3,584,478
New +$45.5M
RXST icon
29
RxSight
RXST
$364M
$43M 1.15%
3,052,796
– –
ENTA icon
30
Enanta Pharmaceuticals
ENTA
$189M
$42.4M 1.13%
896,724
-67,488
-7% -$3.19M
CLYM
31
Climb Bio, Inc. Common Stock
CLYM
$165M
$39.7M 1.06%
13,150,849
– –
RLMD icon
32
Relmada Therapeutics
RLMD
$48.8M
$38M 1.01%
2,000,000
– –
TIL icon
33
Instil Bio
TIL
$196M
$35.4M 0.94%
7,670,793
+2,800,000
+57% +$12.9M
ICVX
34
DELISTED
Icosavax, Inc. Common Stock
ICVX
$34.2M 0.91%
5,963,565
– –
RNA icon
35
Avidity Biosciences
RNA
$6.12B
$31.5M 0.84%
2,167,391
– –
DSGN icon
36
Design Therapeutics
DSGN
$339M
$30.6M 0.82%
2,186,636
– –
ANTX icon
37
AN2 Therapeutics
ANTX
$35.3M
$29.1M 0.77%
3,748,389
+81,726
+2% +$633K
RCKT icon
38
Rocket Pharmaceuticals
RCKT
$358M
$29M 0.77%
2,107,149
– –
EYPT icon
39
EyePoint Pharmaceuticals
EYPT
$827M
$26.5M 0.71%
3,370,506
– –
ETNB icon
40
89bio
ETNB
$1.37B
$25.1M 0.67%
7,782,669
+2,816,900
+57% +$9.07M
STSA
41
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$24.5M 0.65%
5,914,252
– –
PMVP icon
42
PMV Pharmaceuticals
PMVP
$82.1M
$24.4M 0.65%
1,710,265
– –
VERA icon
43
Vera Therapeutics
VERA
$1.47B
$21.5M 0.57%
1,578,820
-387,264
-20% -$5.27M
VRNA
44
Verona Pharma
VRNA
$9.18B
$21.4M 0.57%
5,100,000
– –
RYTM icon
45
Rhythm Pharmaceuticals
RYTM
$6.75B
$20.2M 0.54%
4,871,067
– –
TNYA icon
46
Tenaya Therapeutics
TNYA
$192M
$20M 0.53%
3,551,508
– –
DYN icon
47
Dyne Therapeutics
DYN
$1.92B
$19.3M 0.51%
2,805,045
– –
HLVX icon
48
HilleVax
HLVX
$105M
$19.2M 0.51%
+1,760,019
New +$19.2M
GH icon
49
Guardant Health
GH
$8.11B
$19.2M 0.51%
476,380
– –
PRDS
50
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$19M 0.51%
6,175,038
– –
1
2
3 4 5